As some of you know 'EPIC' is open in 76 locations globally.
A Phase 3 Randomized, Open-Label Study of ponatinib versus imatinib in Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Patients will be randomized in a 1:1 fashion, stratified by Sokal risk score at diagnosis (low, intermediate, high), to receive once daily oral administration of either ponatinib or imatinib.
The following UK centres are open and recruiting:
St. James University Hospital, Site #540 Recruiting
Leeds, United Kingdom,
Royal Liverpool University Hospital, Site #969 Recruiting
Liverpool, United Kingdom,
Newcastle University, Site #970 Recruiting
Newcastle, United Kingdom
Contact: Stephen O'Brien
Nottingham University Hospitals NHS Trust, Site #968 Recruiting
Nottingham, United Kingdom
Contact: Jennifer Byrne
Although it is not yet identified on CT.gov I understand that Hammersmith Hospital, London is also open and recruiting.
See Clinical Trials page on this site for link and full details and list of sites with contact details throughout Europe, as well as other regions
including:
Australia,
4 centres
Belgium
1 centre
Canada,
2 centres
Finland
1 centre
Germany
7 centres
Italy
5 centres
Korea, Republic of
1 centre
New Zealand
3 centres
Singapore
1 centre
Spain
5 centres
Sweden
6 centres
Switzerland
1 centre